Sort   by:  
 Page size 
Mass spectrometric analysis of MM cell-purified B-cell maturation antigen (BCMA) protein to identify ubiquitylation sites.
ORGANISM(S): Homo sapiens (Human) 
2025-07-29 | PXD056372 | Pride
Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with Multiple Myeloma
Decoding Plasma Cell Maturation Dynamics with BCMA
RNASeq: lenalidomide-treated anti-BCMA CAR T cells
This submission contains de-identified Olink NPX affinity proteomics data from longitudinal peripheral blood samples collected from patients with relapsed/refractory multiple myeloma treated with BCMA-directed CAR-T therapy (ide-cel or cilta-cel) in a prospective single-center pilot study. Samples w...
ORGANISM(S): Homo sapiens (Human) 
2026-04-28 | PAD000041 | Pride
Chimeric antigen receptor T-cells (CAR-T) targeting B-cell-maturating-antigen (TNRFSF17, BCMA) show unprecedented overall response rates of up to 100% in heavily pretreated relapsed-refractory Multiple Myeloma (RRMM). However, the efficiency of the treatment is hindered by the rapid emergence of tum...
ORGANISM(S): Homo sapiens 
2020-12-30 | GSE143317 | GEO
Single cell RNA sequencing of TSCM predominnant allogeneic anti-BCMA CAR-T cells
The B cell maturation antigen (BCMA) is dispensable for long-lived plasma cell survival
Plasma cells provide protective antibodies following an infection or vaccination. A network of intrinsic and extrinsic factors fine-tunes the generation of a heterogenous plasma cell pool with varying metabolic requirements, transcriptional profiles and lifespans. Among these intrinsic factors, the ...
ORGANISM(S): Mus musculus 
2025-04-02 | GSE276846 | GEO
Reconstitution of the Multiple Myeloma Microenvironment Following Lymphodepletion with BCMA CAR-T Therapy
Sort   by:  
 Page size